banner

CLSA Wire

CLSA Applauds House Passage of 21st Century Cures Act

344 to 77 House vote demonstrates strong bipartisan support for H.R. 6
 

SAN DIEGO, Calif., July 10, 2015 – California Life Sciences Association (CLSA), the nation’s largest statewide life sciences public policy, advocacy and business solutions organization serving over 750 life sciences organizations, issued the following statement from CLSA President & CEO Sara Radcliffe applauding today’s House passage of H.R. 6, the 21st Century Cures Act, a comprehensive legislative package to accelerate the pace of biomedical research and development in the U.S:

“On behalf of the more than 750 life sciences organizations we represent, CLSA applauds the House for approving the 21st Century Cures Act by a strong, bipartisan vote of 344 to 77. This landmark legislation will spur scientific discovery and biomedical innovation, providing hope for patients and their families, while also protecting jobs and America’s leadership role in healthcare innovation.

“CLSA especially acknowledges and appreciates the 43 bipartisan members of the California congressional delegation who voted in favor of H.R. 6: Reps. Pete Aguilar (D- Redlands); Xavier Becerra (D-Los Angeles); Ami Bera (D-Sacramento); Julia Brownley (D-Thousand Oaks); Ken Calvert (R-Corona);  Lois Capps (D-Santa Barbara); Tony Cardenas (D-Van Nuys); Judy Chu (D-Pasadena); Paul Cook (R-Yucca Valley); Jim Costa (D-Fresno); Susan Davis (D-San Diego); Jeff Denham (R-Atwater); John Garamendi (D-Davis); Janice Hahn (D-Carson); Mike Honda (D-Santa Clara); Jared Huffman (D-San Rafael); Duncan Hunter (R-El Cajon); Steve Knight (R-Palmdale); Doug LaMalfa (R-Redding); Ted Lieu (D-Santa Monica); Alan Lowenthal (D-Long Beach); Doris Matsui (D-Sacramento); Kevin McCarthy (R-Bakersfield); Jerry McNerney (D-Stockton); Grace Napolitano (D-El Monte); Devin Nunes (R-Visalia);  Nancy Pelosi (D-San Francisco); Scott Peters (D-La Jolla); Dana Rohrabacher (R-Laguna Beach); Lucille Roybal-Allard (D-Commerce); Ed Royce (R-Brea); Raul Ruiz (D-Palm Desert); Linda Sanchez (D Cerritos);  Adam Schiff (D-Burbank); Brad Sherman (D-Sherman Oaks); Eric Swalwell (D-Dublin); Mark Takano (D-Riverside); Mike Thompson (D-Napa); Norma Torres (D-Ontario); David Valadao (R-Hanford); Juan Vargas (D-Chula Vista); Mimi Walters (R-Irvine); and Maxine Waters (D-Los Angeles).

“The 21st Century Cures Act is a visionary piece of legislation critical to ensuring that California and the U.S. remains the worldwide leader in life sciences research, investment, and innovation. Attention now turns to the Senate, and we look forward to working with Senators on their ideas and priorities for advancing biomedical research and development. We encourage the Senate to move quickly in advancing this legislation through the chamber and to the president’s desk.”

Learn more about the 21st Century Cures initiative.

Read Sara Radcliffe’s Op-Ed in Roll Call on the 21st Century Cures initiative.

About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice for California’s life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California’s life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state’s most influential life sciences advocacy and business leadership organization. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.

Contact:
Will Zasadny
Manager, Communications for CLSA
Wzasadny@califesciences.org
619-961-8848